Breaking News on Contract Research, Manufacturing & Clinical Trials

Product news > Phase III-IV

Latest news headlines

Products

Suppliers

PPD says new CEO's Pfizer experience will guide partnerships

24-May-2012 - US CRO Pharmaceutical Product Development (PPD) predicts that new CEO Dave Simmons' ‘pharmaceutical industry experience’ gained at Pfizer will be an asset in guiding partnerships.

Quality research key to Pharma viability say execs at Avoca Summit

16-May-2012 - Ensuring outsourced clinical research is of a high standard is critical to the viability of the pharma sector and requires cross industry collaboration according to leaders gathered at the Avoca Group’s Quality Summit.

Medidata beats expectations as cross-selling activity ramps up

03-May-2012 - A doubling in the percentage of new clients buying more than one product helped Medidata beat first quarter expectations.

Chiltern sets up in Taiwan

02-May-2012 - Chiltern has set up a legal entity in Taiwan that will allow it to establish its own local clinical research operations for the first time.

Parexel posts huge bookings & begins another hiring spree

02-May-2012 - Gross bookings at Parexel topped $1bn in the third quarter but the need to accelerate hiring again led to a cut to earnings guidance.

How much does the chief earn – CEO pay at CROs fiscal 2011

30-Apr-2012 - Outsourcing-Pharma looks at the wages of the remaining big four public CROs and how they compare to operating income.

Pharmas and CROs to meet to discuss quality management at Avoca summit

26-Apr-2012 - Pharma sponsors and leading CROs will come together next week at a ‘Quality Summit’ held by consulting and research survey firm the Avoca Group.

IT spend helps Icon win two big deals with non-strategic clients

25-Apr-2012 - New business awards at Icon soared in the first quarter after IT investments helped it win two big deals with non-strategic clients.

Quintiles names consulting services expert as CEO

24-Apr-2012 - Quintiles’ decision to hire Accenture’s Tom Pike as its new CEO suggests consulting services will be even more important in the future for the world’s largest CRO. 

Icon sales up 10% in Q1

24-Apr-2012 - Icon posted double-digit year-on-year sales growth and an uptick, excluding one-off charges, in operating income.

INC plans 600-strong dedicated unit to serve Astellas FSP deal

18-Apr-2012 - INC Research has formed a FSP deal with Astellas and is building a 600-strong dedicated unit to serve the relationship.

inVentiv responds to Moody’s concerns about integration

18-Apr-2012 - inVentiv CEO says PharmaNet and i3 integration ‘essentially complete’ and that – while demand from individual customers can fluctuate - the combination of the two businesses is creating new opportunities.

inVentiv rated ‘negative’ by Moody’s on integration concerns

17-Apr-2012 - Moody’s Investors Service has cut its rating of inVentiv Health, suggesting the firm's recently expanded CRO business faces 'continued challenges.'

Almac lauds benefits of lean six sigma for IXRS biz

16-Apr-2012 - Almac says the adoption of ‘lean six sigma’ was the right move for its clinical technologies business, even taking higher initial training costs into account.

ERT CEO says takeover will give flexibility and that no layoffs are planned

11-Apr-2012 - Acquisition by private equity group Genstar Capital would allow eResearch Technologies (ERT) a more flexible approach and reduce costs according to CEO Jeff Litwin.

ERT attracts $400m takeover bid from PRA owner Genstar Capital

10-Apr-2012 - eResearchTechnology (ERT) has received a $400m (€305m) takeover bid from private equity group Genstar Capital LLC.

India strengthening clinical trial regulatory capacity, gov says

10-Apr-2012 - The Indian regulator is adding staff and strengthening infrastructure to enforce its new clinical trial guidelines, a government minister said.

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

05-Apr-2012 - Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

GE buys genomic services CRO

05-Apr-2012 - GE Healthcare has bought a nucleic acid technology CRO, SeqWright, to add to its range of genomic services.

INC & inVentiv must integrate buys quickly to compete; S&P

03-Apr-2012 - INC Research and inVentiv Health must “quickly and effectively” integrate acquisitions to compete with other CROs, S&P said.

EMA seeks greater engagement with industry to connect silos

02-Apr-2012 - The EMA wants greater engagement from the drug industry to help it modernise regulation and join the "unconnected boxes" that separate stakeholders. 

Failures of medical care more common at CROs, report finds

02-Apr-2012 - Inspectors are more likely to find medical care failings at CROs than sponsors, a Health Canada report found.

INC updates on plans to close former Kendle office

29-Mar-2012 - INC Research says the closure of former Kendle office in Connecticut will better balance resources and that – where possible – staff will be reassigned.

News in brief

INC Research to close former Kendle office with loss of 66 jobs

28-Mar-2012 - US CRO INC Research will close an office it gained through its acquisition of Kendle International last year.

Strategic deals boost satisfaction levels but CROs still need to deliver on costs

28-Mar-2012 - New research suggests that – in general - strategic partnerships are working but CROs still need to improve on sponsors’ ‘high priority’ objectives or risk losing deals.